What's Happening?
DiCello Levitt has announced the addition of Steven Groopman as a partner in its antitrust and competition litigation practice group. Groopman brings extensive experience in leading antitrust cases against
pharmaceutical companies for delaying generic competition and against real estate brokerages for collusion. His expertise also includes handling cases related to unlawful debt collection and consumer protection violations. Groopman joins DiCello Levitt from Berman Tabacco, enhancing the firm's capabilities in tackling complex antitrust issues.
Why It's Important?
The expansion of DiCello Levitt's antitrust practice with Groopman's expertise highlights the growing focus on antitrust litigation in the U.S., particularly in sectors like pharmaceuticals and real estate. This move reflects the increasing scrutiny on corporate practices that may hinder competition and consumer rights. As antitrust issues gain prominence in legal and regulatory circles, law firms are bolstering their teams to address these challenges. Groopman's addition is likely to strengthen DiCello Levitt's position in high-stakes antitrust litigation, potentially influencing outcomes in significant cases.
